Zentalis: Latest Market Sell-Off Looks Justified With Data Catalysts Long Way Off (NASDAQ:ZNTL)


binoculars on top of rock mountain at sunset

AUNG MYO HTWE/iStock via Getty Images

Investment Overview: Zentalis Believes ‘Pipeline-In-A-Pill” Azenosertib Will Soon Make Grade In Ovarian Cancer

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) is a clinical-stage biotech headquartered in New York that was listed on the Nasdaq in April



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *